135 results match your criteria: "Dysautonomia Center[Affiliation]"

Objective: Blunted tachycardia during hypotension is a characteristic feature of patients with autonomic failure, but the range has not been defined. This study reports the range of orthostatic heart rate (HR) changes in patients with autonomic failure caused by neurodegenerative synucleinopathies.

Methods: Patients evaluated at sites of the U.

View Article and Find Full Text PDF

Background: Putaminal diffusivity in brain magnetic resonance diffusion-weighted imaging (DWI) is increased in patients with the parkinsonian variant of multiple system atrophy (MSA-P) compared to Parkinson disease (PD) patients.

Purpose: We performed a systematic review and meta-analysis to evaluate the diagnostic accuracy of DWI to distinguish MSA-P from PD.

Methods: Studies on DWI were identified through a systematic PubMed and Clarivate Analytics® Web of Science® Core Collection search.

View Article and Find Full Text PDF

Background: Chronic lung disease is a leading cause of premature death in patients with familial dysautonomia (FD). A significant number of patients have obstructive airway disease, yet it is not known whether this is pharmacologically reversible.

Methods: We conducted a double-blind, placebo-controlled, randomized clinical trial comparing the beta 2 agonist albuterol with the muscarinic blocker ipratropium bromide in patients homozygous for the IKBKAP founder mutation.

View Article and Find Full Text PDF

Diagnosis of multiple system atrophy.

Auton Neurosci

May 2018

Department of Neurology, Dysautonomia Center, New York University School of Medicine, NY, USA. Electronic address:

Multiple system atrophy (MSA) may be difficult to distinguish clinically from other disorders, particularly in the early stages of the disease. An autonomic-only presentation can be indistinguishable from pure autonomic failure. Patients presenting with parkinsonism may be misdiagnosed as having Parkinson disease.

View Article and Find Full Text PDF

Pharmacotherapy of Cardiovascular Autonomic Dysfunction in Parkinson Disease.

CNS Drugs

November 2017

Department of Neurology, NYU Langone Medical Center, Dysautonomia Center, 530 1st Avenue, New York, NY, USA.

Cardiovascular autonomic dysfunctions, including neurogenic orthostatic hypotension, supine hypertension and post-prandial hypotension, are relatively common in patients with Parkinson disease. Recent evidence suggests that early autonomic impairment such as cardiac autonomic denervation and even neurogenic orthostatic hypotension occur prior to the appearance of the typical motor deficits associated with the disease. When neurogenic orthostatic hypotension develops, patients with Parkinson disease have an increased risk of mortality, falls, and trauma-related to falls.

View Article and Find Full Text PDF

Background: Orthostatic hypotension (OH) is a sustained fall in blood pressure on standing which can cause symptoms of organ hypoperfusion. OH is associated with increased morbidity and mortality and leads to a significant number of hospital admissions particularly in the elderly (233 per 100,000 patients over 75 years of age in the US). OH can be due to volume depletion, blood loss, large varicose veins, medications, or due to defective activation of sympathetic nerves and reduced norepinephrine release upon standing (i.

View Article and Find Full Text PDF

Purpose: To report the use of intranasal dexmedetomidine, an α-adrenergic agonist for the acute treatment of refractory adrenergic crisis in patients with familial dysautonomia.

Methods: Case series.

Results: Three patients with genetically confirmed familial dysautonomia (case 1: 20-year-old male; case 2: 43-year-old male; case 3: 26-year-old female) received intranasal dexmedetomidine 2 mcg/kg, half of the dose in each nostril, for the acute treatment of adrenergic crisis.

View Article and Find Full Text PDF

Droxidopa for symptomatic neurogenic orthostatic hypotension: what can we learn?

Clin Auton Res

July 2017

Department of Neurology, Dysautonomia Center, New York University School of Medicine, 530 First Avenue, Suite 9Q, New York, NY, 10017, USA.

View Article and Find Full Text PDF

Neurogenic orthostatic hypotension: the very basics.

Clin Auton Res

July 2017

Department of Neurology, Dysautonomia Center, New York University School of Medicine, 530 First Avenue, Suite 9Q, New York, NY, 10017, USA.

View Article and Find Full Text PDF

Background: Multiple system atrophy (MSA) is a rare, adult-onset, rapidly progressive fatal synucleinopathy that primarily affects oligodendroglial cells in the brain. Patients with MSA only rarely have visual complaints, but recent studies of the retina using optical coherence tomography (OCT) showed atrophy of the peripapillary retinal nerve fiber layer (RNFL) and to a lesser extent the macular ganglion cell layer (GCL) complex.

Methods: We performed a literature review and meta-analysis according to the preferred reporting items for systematic reviews and meta-analyses guidelines for studies published before January 2017, identified through PubMed and databases, which reported OCT-related outcomes in patients with MSA and controls.

View Article and Find Full Text PDF

Study Objectives: Sudden unexpected death during sleep (SUDS) is the most common cause of death in patients with familial dysautonomia (FD), an autosomal recessive disease characterized by sensory and autonomic dysfunction. It remains unknown what causes SUDS in these patients and who is at highest risk. We tested the hypothesis that SUDS in FD is linked to sleep-disordered breathing.

View Article and Find Full Text PDF

Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension.

BMC Neurol

May 2017

Department of Neurology, Dysautonomia Center, New York University School of Medicine, 530 First Avenue, Suite 9Q, New York, NY, 10016, USA.

Background: Droxidopa, a prodrug of norepinephrine, was approved for treatment of neurogenic orthostatic hypotension (nOH) due to primary autonomic disorders based on 3 randomized double-blind studies. We performed safety and efficacy analyses of this pooled dataset (n = 460).

Methods: Efficacy was assessed using Orthostatic Hypotension Questionnaire (OHQ) scores (composite and individual items).

View Article and Find Full Text PDF

Pathological Confirmation of Optic Neuropathy in Familial Dysautonomia.

J Neuropathol Exp Neurol

March 2017

Department of Neurology, Dysautonomia Center, NYU Langone Medical Center, New York University, New York, USA.

Clinical data suggest that optic neuropathy and retinal ganglion cell loss are the main cause of visual decline in patients with familial dysautonomia, but this has not previously been confirmed by pathological analyses. We studied retinas and optic nerves in 6 eyes from 3 affected patients obtained at autopsy. Analyses included routine neurohistology and immunohistochemistry for neurofilaments, cytochrome c oxidase (COX), and melanopsin-containing ganglion cells.

View Article and Find Full Text PDF

The Optical Coherence Tomographic Profile of Leber Hereditary Optic Neuropathy.

Neuroophthalmology

June 2016

New England Eye Center, Tufts Medical Center, Tufts University, Boston, Massachusetts, USA; Dysautonomia Center, Department of Neurology, New York University School of Medicine, New York, New York, USA; Department of Ophthalmology, Pontifical Catholic University of Chile, Santiago de Chile, Chile.

The objective of this study was to describe the changes in the retinal ganglion cell complex (GCC) relative to the retinal nerve fibre layer (RNFL) over time in Leber hereditary optic neuropathy (LHON) patients. Average RNFL and GCC thickness was measured in seven patients in the early acute (123, 68.4 μm), late acute (113.

View Article and Find Full Text PDF

Cardiovascular autonomic and hemodynamic responses to vagus nerve stimulation in drug-resistant epilepsy.

Seizure

February 2017

Autonomic and Movement Disorders Unit, Biocruces Research Institute, Barakado, Bizkaia, Spain; Department of Neurosciences, University of Basque Country, Leioa, Spain. Electronic address:

Purpose: Vagus nerve stimulation (VNS) is used as an adjunctive therapy for treating patients with drug-resistant epilepsy. The impact of VNS on cardiovascular autonomic function remains to be fully understood. We determined changes in cardiovascular sympathetic and parasympathetic, and hemodynamic function in association with VNS in patients with drug-resistant focal epilepsy.

View Article and Find Full Text PDF

Brain structural profile of multiple system atrophy patients with cognitive impairment.

J Neural Transm (Vienna)

March 2017

Parkinson Disease and Movement Disorders Unit, IRCCS San Camillo Hospital Foundation, via Alberoni, 70, 30126, Venice-Lido, Italy.

Current consensus diagnostic criteria for multiple system atrophy (MSA) consider dementia a non-supporting feature, although cognitive impairment and even frank dementia are reported in clinical practice. Mini-Mental State Examination (MMSE) is a commonly used global cognitive scale, and in a previous study, we established an MSA-specific screening cut-off score <27 to identify cognitive impairment. Finally, MSA neuroimaging findings suggest the presence of structural alterations in patients with cognitive deficits, although the extent of the anatomical changes is unclear.

View Article and Find Full Text PDF

Dexmedetomidine for refractory adrenergic crisis in familial dysautonomia.

Clin Auton Res

February 2017

Department of Neurology, Dysautonomia Center, New York University School of Medicine, 530 First Avenue Suite 9Q, New York, NY, 10016, USA.

Objective: Adrenergic crises are a cardinal feature of familial dysautonomia (FD). Traditionally, adrenergic crises have been treated with the sympatholytic agent clonidine or with benzodiazepines, which can cause excessive sedation and respiratory depression. Dexmedetomidine is a centrally-acting α -adrenergic agonist with greater selectivity and shorter half-life than clonidine.

View Article and Find Full Text PDF

Study Objectives: In familial dysautonomia (FD) patients, sleep-disordered breathing (SDB) might contribute to their high risk of sleep-related sudden death. Prevalence of central versus obstructive sleep apneas is controversial but may be therapeutically relevant. We, therefore, assessed sleep structure and SDB in FD-patients with no history of SDB.

View Article and Find Full Text PDF

Purpose: To determine whether a pattern of altitudinal ganglion cell loss, as detected and measured by optical coherence tomography (OCT), can be used to distinguish non-arteritic ischaemic optic neuropathy (NAION) from optic neuritis (ON) during the acute phase, and whether the rate or severity of ganglion cell loss differs between the two diseases.

Methods: We performed a retrospective, case-control study of 44 patients (50 eyes) with ON or NAION and 44 age-matched controls. Non-arteritic ischaemic optic neuropathy and ON patients had OCT at presentation and four consecutive follow-up visits.

View Article and Find Full Text PDF

Tocotrienol Treatment in Familial Dysautonomia: Open-Label Pilot Study.

J Mol Neurosci

July 2016

Department of Developmental Biology and Cancer Research, The Hebrew University, Hadassah School of Medicine, Jerusalem, Israel.

Familial dysautonomia (FD) is an autosomal recessive congenital neuropathy, primarily presented in Ashkenazi Jews. The most common mutation in FD patients results from a single base pair substitution of an intronic splice site in the IKBKAP gene which disrupts normal mRNA splicing and leads to tissue-specific reduction of IKBKAP protein (IKAP). To date, treatment of FD patients remains preventative, symptomatic and supportive.

View Article and Find Full Text PDF